Back to
Citigroup Inc.
SMMT
Showing 9 of 12 quarters
Position history for
Citigroup Inc.'s holdings in Summit Therapeutics Inc.
Yes. Citigroup holds 510,193 shares of SMMT (Summit Therapeutics), worth $8.6M, as of its Q3 2026 13F filing. It reduced the position by 203,807 shares (-28.5%) from Q2 2026. Citigroup has held SMMT in every 13F on record since Q4 2023, 12 quarterly filings.
Current Value
$8.6M
Current Shares
510,193
Total Value Change
+$7M
Total Shares Change
+434,058
Quarter-by-Quarter History